$1 billion Google Cloud deal to enhance Merck & Co’s ‘digital backbone as an AI-enabled enterprise’ - The Pharma Letter
$1 billion Google Cloud deal to enhance Merck & Co’s ‘digital backbone as an AI-enabled enterprise’ The Pharma Letter
Merck & Co Company News
Merck & Co., Inc. (MRK) to Release Earnings on Thursday - MarketBeat
Merck & Co., Inc. (MRK) to Release Earnings on Thursday MarketBeat
Merck & Co. goes all-in on agentic AI via $1B Google Cloud deal - FirstWord Pharma
Merck & Co. goes all-in on agentic AI via $1B Google Cloud deal FirstWord Pharma
Merck to partner with Google Cloud on AI initiatives - Reuters
Merck to partner with Google Cloud on AI initiatives Reuters
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) ChartMill
United Asset Strategies Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
United Asset Strategies Inc. Boosts Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co Inc Stock (MRK) Moved Down by 4.19% on Apr 21: A Full Analysis - TradingKey
Merck & Co Inc Stock (MRK) Moved Down by 4.19% on Apr 21: A Full Analysis TradingKey
Merck & Co., Inc. $MRK Shares Sold by Teacher Retirement System of Texas - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Teacher Retirement System of Texas MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Caprock Group LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Caprock Group LLC MarketBeat
B. Metzler seel. Sohn & Co. AG Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
B. Metzler seel. Sohn & Co. AG Increases Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
KLP Kapitalforvaltning AS Cuts Position in Merck & Co., Inc. $MRK - MarketBeat
KLP Kapitalforvaltning AS Cuts Position in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH MarketBeat
PFG Advisors Sells 11,759 Shares of Merck & Co., Inc. $MRK - MarketBeat
PFG Advisors Sells 11,759 Shares of Merck & Co., Inc. $MRK MarketBeat
CPC Advisors LLC Increases Position in Merck & Co., Inc. $MRK - MarketBeat
CPC Advisors LLC Increases Position in Merck & Co., Inc. $MRK MarketBeat
Novem Group Purchases 9,205 Shares of Merck & Co., Inc. $MRK - MarketBeat
Novem Group Purchases 9,205 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Boston Trust Walden Corp - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Boston Trust Walden Corp MarketBeat
Duncker Streett & Co. Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Duncker Streett & Co. Inc. Boosts Holdings in Merck & Co., Inc. $MRK MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Zurcher Kantonalbank Zurich Cantonalbank MarketBeat
TD Waterhouse Canada Inc. Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
TD Waterhouse Canada Inc. Grows Holdings in Merck & Co., Inc. $MRK MarketBeat
Wealth Enhancement Trust Services Inc. Buys New Position in Merck & Co., Inc. $MRK - MarketBeat
Wealth Enhancement Trust Services Inc. Buys New Position in Merck & Co., Inc. $MRK MarketBeat
The top 20 pharma companies by 2025 revenue - Fierce Pharma
The top 20 pharma companies by 2025 revenue Fierce Pharma
Our Q4 and full-year 2025 financial results - Merck
Our Q4 and full-year 2025 financial results Merck
Ninety One UK Ltd Sells 14,696 Shares of Merck & Co., Inc. $MRK - MarketBeat
Ninety One UK Ltd Sells 14,696 Shares of Merck & Co., Inc. $MRK MarketBeat
Symmetry Partners LLC Increases Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Symmetry Partners LLC Increases Stock Holdings in Merck & Co., Inc. $MRK MarketBeat
Tokio Marine Asset Management Co. Ltd. Reduces Stake in Merck & Co., Inc. $MRK - MarketBeat
Tokio Marine Asset Management Co. Ltd. Reduces Stake in Merck & Co., Inc. $MRK MarketBeat
Merck to split cancer, specialty drug businesses in leadership shakeup - BioPharma Dive
Merck to split cancer, specialty drug businesses in leadership shakeup BioPharma Dive
The new manufacturing facilities powering our US growth - Merck
The new manufacturing facilities powering our US growth Merck
Merck's cholesterol drug meets main goal in head-to-head trial - Reuters
Merck's cholesterol drug meets main goal in head-to-head trial Reuters
Whittier Trust Co. of Nevada Inc. Sells 11,310 Shares of Merck & Co., Inc. $MRK - MarketBeat
Whittier Trust Co. of Nevada Inc. Sells 11,310 Shares of Merck & Co., Inc. $MRK MarketBeat
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. - Business Wire
Merck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc. Business Wire
Merck & Co.'s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
Merck & Co.'s Quarterly Earnings Preview: What You Need to Know Yahoo Finance
Strong Results Lifted Merck & Co (MRK) in Q4 - Yahoo Finance
Strong Results Lifted Merck & Co (MRK) in Q4 Yahoo Finance
Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma
Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss - Yahoo Finance
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss Yahoo Finance
Jim Cramer on Merck & Co.: “This Is One of My Favorite Pharmaceutical Stocks” - Yahoo Finance
Jim Cramer on Merck & Co.: “This Is One of My Favorite Pharmaceutical Stocks” Yahoo Finance
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline - BioSpace
Merck Bats Away ‘Modest Growth’ Accusations, Touts Broad Pipeline BioSpace
Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion - Yahoo Finance
Merck & Co. (MRK) to Acquire Terns Pharma for $6.7 Billion Yahoo Finance
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms - BioSpace
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms BioSpace
Merck & Co.'s Q4 2025 Earnings: What to Expect - Yahoo Finance
Merck & Co.'s Q4 2025 Earnings: What to Expect Yahoo Finance